Clara Ribas-Llauradó
2PUBLICATIONS
6CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (2)
Sort by Publication Date:
|Mar 28, 2023
Remibrutinib inhibits hives effector cells stimulated by serum from chronic urticaria patients independently of FcεR1 expression level and omalizumab clinical response.Ramón Gimeno, Clara Ribas-Llauradó, David Pesque
|Feb 07, 2022
IgE and high-affinity IgE receptor in chronic inducible urticaria, pathogenic, and management relevance.Ana M Giménez-Arnau, Clara Ribas-Llauradó, Nasser Mohammad-Porras
Pageof 1
